2016 Vol.34, N°5 - Suppl.100 - Table of contents
Scleroderma 2016
9th Annual Supplement on Systemic Sclerosis
Guest Editor: S. Bombardieri
One year in review
CER9732
2016,34,5,Suppl.100
Pg. 0003-0013
Free to view
One year in review 2016: systemic sclerosis
S. Barsotti, C. Stagnaro, A. D'ascanio, A. Della Rossa
S. Barsotti, C. Stagnaro, A. D'ascanio, A. Della Rossa
Aetiopathogenesis
CER8635
2016,34,5,Suppl.100
Pg. 0014-0022
Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis
L. Lei, C. Zhao, F. Qin, Z.-Y. He, X. Wang, X.-N. Zhong
L. Lei, C. Zhao, F. Qin, Z.-Y. He, X. Wang, X.-N. Zhong
CER8799
2016,34,5,Suppl.100
Pg. 0023-0029
Anti-fibrotic characteristics of Vγ9+ γδ T cells in systemic sclerosis
N. Markovits, A. Bendersky, R. Loebstein, M. Brusel, E. Kessler, I. Bank
N. Markovits, A. Bendersky, R. Loebstein, M. Brusel, E. Kessler, I. Bank
CER8819
2016,34,5,Suppl.100
Pg. 0030-0036
Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis
D. Simon, P. Balogh, A. Bognár, Z. Kellermayer, P. Engelmann, P. Németh, N. Farkas, T. Minier, V. Lóránd, L. Czirják, T. Berki
D. Simon, P. Balogh, A. Bognár, Z. Kellermayer, P. Engelmann, P. Németh, N. Farkas, T. Minier, V. Lóránd, L. Czirják, T. Berki
CER8981
2016,34,5,Suppl.100
Pg. 0037-0042
Different contributions of angiostatin and endostatin in angiogenesis impairment in systemic sclerosis: a cohort study
I. Almeida, A. Oliveira Gomes, M. Lima, I. Silva, C. Vasconcelos
I. Almeida, A. Oliveira Gomes, M. Lima, I. Silva, C. Vasconcelos
CER9140
2016,34,5,Suppl.100
Pg. 0043-0048
A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosis
E. Koumakis, M. Bouaziz, P. Dieudé, A. Cauvet, B. Ruiz, P. Airò, D. Cusi, M. Matucci-Cerinic, E. Salvi, G. Cuomo, E. Hachulla, E. Diot, P. Caramaschi, V. Riccieri, J. Avouac, Y. Allanore
E. Koumakis, M. Bouaziz, P. Dieudé, A. Cauvet, B. Ruiz, P. Airò, D. Cusi, M. Matucci-Cerinic, E. Salvi, G. Cuomo, E. Hachulla, E. Diot, P. Caramaschi, V. Riccieri, J. Avouac, Y. Allanore
Clinical aspects
CER8772
2016,34,5,Suppl.100
Pg. 0049-0055
Clinical, autoimmune, and psychiatric parameters correlate with sleep disturbance in patients with systemic sclerosis and rheumatoid arthritis
G.L. Bagnato, A. Fiorenza, F. Cordova, W.N. Roberts, C. Moore, Jr., D. Greco, C. Monaco, M.R.A. Muscatello, A. Bruno, R. Zoccali, G. Bagnato
G.L. Bagnato, A. Fiorenza, F. Cordova, W.N. Roberts, C. Moore, Jr., D. Greco, C. Monaco, M.R.A. Muscatello, A. Bruno, R. Zoccali, G. Bagnato
CER9093
2016,34,5,Suppl.100
Pg. 0056-0062
Reasons for non-participation in scleroderma support groups
V.C. Delisle, S.T. Gumuchian, S. Pelaez, V.L. Malcarne, G. El-Baalbaki, A. Körner, M. Hudson, M. Baron, B.D. Thombs
and the Scleroderma Support Group Project Advisory Team
V.C. Delisle, S.T. Gumuchian, S. Pelaez, V.L. Malcarne, G. El-Baalbaki, A. Körner, M. Hudson, M. Baron, B.D. Thombs
and the Scleroderma Support Group Project Advisory Team
CER9103
2016,34,5,Suppl.100
Pg. 0063-0069
Esophageal and anorectal involvement in systemic sclerosis: a systematic assessment with high resolution manometry
L. Luciano, B. Granel, E. Bernit, J.-R. Harle, K. Baumstarck, J.-C. Grimaud, M. Bouvier, V. Vitton
L. Luciano, B. Granel, E. Bernit, J.-R. Harle, K. Baumstarck, J.-C. Grimaud, M. Bouvier, V. Vitton
CER9236
2016,34,5,Suppl.100
Pg. 0070-0073
African American race associated with body image dissatisfaction among patients with systemic sclerosis
J.S. Nusbaum, J.K. Gordon, V.D. Steen
J.S. Nusbaum, J.K. Gordon, V.D. Steen
CER9216
2016,34,5,Suppl.100
Pg. 0074-0078
One decade distinct features, morbidity and mortality of scleroderma: a cross-sectional study
M.A. Nazarinia, E. Esmaeilzadeh, Y. Emami, A. Salehi
M.A. Nazarinia, E. Esmaeilzadeh, Y. Emami, A. Salehi
CER9238
2016,34,5,Suppl.100
Pg. 0079-0084
Determinants of unemployment amongst Australian systemic sclerosis patients: results from a multicentre cohort study
K. Morrisroe, M. Huq, W. Stevens, C. Rabusa, S.M. Proudman, M. Nikpour
and the Australian Scleroderma Interest Group (ASIG)
K. Morrisroe, M. Huq, W. Stevens, C. Rabusa, S.M. Proudman, M. Nikpour
and the Australian Scleroderma Interest Group (ASIG)
CER9305
2016,34,5,Suppl.100
Pg. 0085-0091
Insulin resistance is associated with digital ulcer in patients with systemic sclerosis
E.-K. Park, S.-G. Lee, B.-H. Kim, J.-H. Park, S. Lee, G.-T. Kim
E.-K. Park, S.-G. Lee, B.-H. Kim, J.-H. Park, S. Lee, G.-T. Kim
CER9519
2016,34,5,Suppl.100
Pg. 0092-0099
Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
L.R. Jewett, L. Kwakkenbos, M.-E. Carrier, V.L. Malcarne, S.J. Bartlett, D.E. Furst, K. Gottesman, M.D. Mayes, S. Assassi, D. Harcourt, H. Williamson, S.R. Johnson, A. Körner, V. Steen, R.S. Fox, S. Gholizadeh, S.D. Mills, J.C. Molnar, D.B. Rice, B.D. Thombs
and the SPIN Investigators
L.R. Jewett, L. Kwakkenbos, M.-E. Carrier, V.L. Malcarne, S.J. Bartlett, D.E. Furst, K. Gottesman, M.D. Mayes, S. Assassi, D. Harcourt, H. Williamson, S.R. Johnson, A. Körner, V. Steen, R.S. Fox, S. Gholizadeh, S.D. Mills, J.C. Molnar, D.B. Rice, B.D. Thombs
and the SPIN Investigators
CER9397
2016,34,5,Suppl.100
Pg. 0100-0105
Pilot study assessing pathophysiology and healing of digital ulcers in patients with systemic sclerosis using laser Doppler imaging and thermography
A.K. Murray, T.L. Moore, E. Wragg, H. Ennis, A. Vail, G. Dinsdale, L. Muir, C.E. Griffiths, A.L. Herrick
A.K. Murray, T.L. Moore, E. Wragg, H. Ennis, A. Vail, G. Dinsdale, L. Muir, C.E. Griffiths, A.L. Herrick
CER9761
2016,34,5,Suppl.100
Pg. 0106-0109
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis
B.M. Lynch, E.P. Stern, V. Ong, M. Harber, A. Burns, C.P. Denton
B.M. Lynch, E.P. Stern, V. Ong, M. Harber, A. Burns, C.P. Denton
CER9613
2016,34,5,Suppl.100
Pg. 0110-0114
The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations
Y. Yalçinkaya, S. Çinar, B. Artim-Esen, S. Kamali, L. Öcal, G. Deniz, M. Inanç
Y. Yalçinkaya, S. Çinar, B. Artim-Esen, S. Kamali, L. Öcal, G. Deniz, M. Inanç
Diagnosis
CER8756
2016,34,5,Suppl.100
Pg. 0115-0121
High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity.
J. Raja, C.T. Ng, I. Sujau, K.F. Chin, S. Sockalingam
J. Raja, C.T. Ng, I. Sujau, K.F. Chin, S. Sockalingam
CER9043
2016,34,5,Suppl.100
Pg. 0122-0128
N-terminal pro Brain Natriuretic Peptide as predictor of outcome in scleroderma renal crisis
C.B. Chighizola, F. Pregnolato, P.L. Meroni, C.P. Denton, V.H. Ong
C.B. Chighizola, F. Pregnolato, P.L. Meroni, C.P. Denton, V.H. Ong
CER8524
2016,34,5,Suppl.100
Pg. 0129-0136
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study
V. Thakkar, W. Stevens, D. Prior, C. Rabusa, J. Sahhar, J.G. Walker, J. Roddy, S. Lester, M. Rischmueller, J. Zochling, P. Nash, E. Gabbay, P. Youssef, S.M. Proudman, M. Nikpour
V. Thakkar, W. Stevens, D. Prior, C. Rabusa, J. Sahhar, J.G. Walker, J. Roddy, S. Lester, M. Rischmueller, J. Zochling, P. Nash, E. Gabbay, P. Youssef, S.M. Proudman, M. Nikpour
CER8849
2016,34,5,Suppl.100
Pg. 0137-0141
A preliminary study using virtual touch imaging and quantification for the assessment of skin stiffness in systemic sclerosis
T. Santiago, B. Alcacer-Pitarch, M.J. Salvador, F. Del Galdo, A.C. Redmond, J.A.P. Da Silva
T. Santiago, B. Alcacer-Pitarch, M.J. Salvador, F. Del Galdo, A.C. Redmond, J.A.P. Da Silva
CER9035
2016,34,5,Suppl.100
Pg. 0142-0147
Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis
H.C. Ahrens, E. Siegert, D. Tomsitz, K. Mattat, C. March, M. Worm, G. Riemekasten
H.C. Ahrens, E. Siegert, D. Tomsitz, K. Mattat, C. March, M. Worm, G. Riemekasten
CER9059
2016,34,5,Suppl.100
Pg. 0148-0151
Assessment of sensitivity to change of the European Scleroderma Study Group activity index
K. Melsens, F. De Keyser, S. Decuman, G. Brusselle, M. De Pauw, E. Deschepper, K. De Wilde, D. Elewaut, Y. Piette, E. Vandecasteele, V. Smith
K. Melsens, F. De Keyser, S. Decuman, G. Brusselle, M. De Pauw, E. Deschepper, K. De Wilde, D. Elewaut, Y. Piette, E. Vandecasteele, V. Smith
CER9434
2016,34,5,Suppl.100
Pg. 0152-0156
Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis
F. Someya, N. Mugii, S. Oohata
F. Someya, N. Mugii, S. Oohata
Treatment
CER8704
2016,34,5,Suppl.100
Pg. 0157-0161
Occupational therapy integrated with a self-administered stretching program on systemic sclerosis patients with hand involvement
K. Stefanantoni, I. Sciarra, N. Iannace, M. Vasile, M. Caucci, A. Sili Scavalli, M.P. Massimiani, L. Passi, L. Maset, V. Riccieri
K. Stefanantoni, I. Sciarra, N. Iannace, M. Vasile, M. Caucci, A. Sili Scavalli, M.P. Massimiani, L. Passi, L. Maset, V. Riccieri
CER8457
2016,34,5,Suppl.100
Pg. 0162-0169
Systemic sclerosis: rehabilitation as a tool to cope with disability
S. Maddali-Bongi, A. Del Rosso
S. Maddali-Bongi, A. Del Rosso
CER8955
2016,34,5,Suppl.100
Pg. 0170-0176
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study
C. Owen, G.-S. Ngian, K. Elford, O. Moore, W. Stevens, M. Nikpour, C. Rabusa, S. Proudman, J. Roddy, J. Zochling, C. Hill, A. Sturgess, K. Tymms, P. Youssef, J. Sahhar
C. Owen, G.-S. Ngian, K. Elford, O. Moore, W. Stevens, M. Nikpour, C. Rabusa, S. Proudman, J. Roddy, J. Zochling, C. Hill, A. Sturgess, K. Tymms, P. Youssef, J. Sahhar
CER9255
2016,34,5,Suppl.100
Pg. 0177-0180
Safety and efficacy of extracorporeal shock wave therapy (ESWT) in calcinosis cutis associated with systemic sclerosis
S. Blumhardt, D.P. Frey, M. Toniolo, H. Alkadhi, U. Held, O. Distler
S. Blumhardt, D.P. Frey, M. Toniolo, H. Alkadhi, U. Held, O. Distler
CER9597
2016,34,5,Suppl.100
Pg. 0181-0185
Free to view
Effects of rituximab in connective tissue disorders related interstitial lung disease
G. Lepri, J. Avouac, P. Airò, F. Anguita Santos, S. Bellando-Randone, J. Blagojevic, F. Garcia Hernàndez, J.A. Gonzalez Nieto, S. Guiducci, S. Jordan, V. Limaye, B. Maurer, A. Selva-O'callaghan, V. Riccieri, O. Distler, M. Matucci-Cerinic, Y. Allanore
G. Lepri, J. Avouac, P. Airò, F. Anguita Santos, S. Bellando-Randone, J. Blagojevic, F. Garcia Hernàndez, J.A. Gonzalez Nieto, S. Guiducci, S. Jordan, V. Limaye, B. Maurer, A. Selva-O'callaghan, V. Riccieri, O. Distler, M. Matucci-Cerinic, Y. Allanore
Review
CER9058
2016,34,5,Suppl.100
Pg. 0186-0192
Free to view
Disease activity indices in systemic sclerosis: a systematic literature review
K. Melsens, F. De Keyser, S. Decuman, Y. Piette, E. Vandecasteele, V. Smith
K. Melsens, F. De Keyser, S. Decuman, Y. Piette, E. Vandecasteele, V. Smith
Paediatric Rheumatology
CER8823
2016,34,5,Suppl.100
Pg. 0193-0199
Nailfold videocapillaroscopy in healthy children and adolescents: description of normal patterns
D.P. Piotto, J. Sekiyama, C. Kayser, M. Yamada, C.A. Len, M.T. Terreri
D.P. Piotto, J. Sekiyama, C. Kayser, M. Yamada, C.A. Len, M.T. Terreri
CER9304
2016,34,5,Suppl.100
Pg. 0200-0206
Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoring
C.E. Pain, T. Constantin, N. Toplak, M. Moll, C. Iking-Konert, D.P. Piotto, N. Aktay Ayaz, D. Nemcova, P.H. Hoeger, M. Cutolo, V. Smith, I. Foeldvari
on behalf of the Paediatric Rheumatology European Society (PRES) Juvenile Scleroderma Working Group.
C.E. Pain, T. Constantin, N. Toplak, M. Moll, C. Iking-Konert, D.P. Piotto, N. Aktay Ayaz, D. Nemcova, P.H. Hoeger, M. Cutolo, V. Smith, I. Foeldvari
on behalf of the Paediatric Rheumatology European Society (PRES) Juvenile Scleroderma Working Group.
Letters to the Editor
CER8649
2016,34,5,Suppl.100
Pg. 0207
Free to view
A successful case of second autologous haematopoietic stem cell transplantation for post-transplant systemic sclerosis relapse
Y. Hou, H.-J. Li, M.-T. Li, D. Xu, D.-B. Zhou, X.-F. Zeng
Y. Hou, H.-J. Li, M.-T. Li, D. Xu, D.-B. Zhou, X.-F. Zeng
CER9311
2016,34,5,Suppl.100
Pg. 0208-0209
Free to view
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
A. Márquez, T. Fernández-Aranguren, T. Witte, M.A. González-Gay, J. Martín
Spanish GCA Group, Spanish Scleroderma Group
A. Márquez, T. Fernández-Aranguren, T. Witte, M.A. González-Gay, J. Martín
Spanish GCA Group, Spanish Scleroderma Group
CER9599
2016,34,5,Suppl.100
Pg. 0210
Free to view
Moyamoya disease and systemic sclerosis (MoSys syndrome): a combination of two rare entities
F. Wegner, U. Mueller-Ladner, F.M. Meier
F. Wegner, U. Mueller-Ladner, F.M. Meier